Redx, Jounce announce recommended business combination EP News Bureau Feb 24, 2023 Combined group will have a strong clinical pipeline and proven expertise in the discovery and development of highly selective…
Gilead and Jounce Therapeutics sign exclusive license pact for novel immunotherapy program EP News Bureau Sep 1, 2020 Jounce will lead the development of JTX-1811 through IND clearance, and thereafter, Gilead will have the sole right to develop…
